BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 2444131)

  • 21. Basophil releasability in patients with hymenoptera venom allergy.
    Radermecker MF; Leclercq MD; Mariz SD; Louis RE
    Int Arch Allergy Immunol; 1993; 101(3):283-7. PubMed ID: 7686798
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human basophil releasability. III. Genetic control of human basophil releasability.
    Marone G; Poto S; Celestino D; Bonini S
    J Immunol; 1986 Dec; 137(11):3588-92. PubMed ID: 2431036
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential activation of human basophils by anti-IgE and formyl-methionyl-leucyl-phenylalanine. Indications for protein kinase C-dependent and -independent activation pathways.
    Knol EF; Koenderman L; Mul FP; Verhoeven AJ; Roos D
    Eur J Immunol; 1991 Apr; 21(4):881-5. PubMed ID: 1708341
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The in vitro and in vivo effect of corticosteroids on basophil releasability in patients with mild and severe bronchial asthma.
    Kivity S; Onn A; Agami O; Fireman E
    Clin Exp Allergy; 1997 Aug; 27(8):909-14. PubMed ID: 9291288
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition by somatostatin of the release of mediators from human basophils and rat leukemic basophils.
    Goetzl EJ; Payan DG
    J Immunol; 1984 Dec; 133(6):3255-9. PubMed ID: 6208274
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anaphylactic anaesthetic reactions. The value of paper radioallergosorbent tests for IgE antibodies to muscle relaxants and thiopentone.
    Assem ES
    Anaesthesia; 1990 Dec; 45(12):1032-8. PubMed ID: 1703727
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhanced human basophil activation and histamine release by IL3 priming: application to sulfite allergy diagnosis.
    Sainte-Laudy J; Vallon C; Guerin JC
    Inflamm Res; 1995 Apr; 44 Suppl 1():S3-4. PubMed ID: 8520986
    [No Abstract]   [Full Text] [Related]  

  • 28. In vivo characterization of the anti-inflammatory effect of cyclosporin A on human basophils.
    Casolaro V; Spadaro G; Patella V; Marone G
    J Immunol; 1993 Nov; 151(10):5563-73. PubMed ID: 7693814
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Study of IgE-dependent basophil releasability in allergic patients.
    Sanz ML; Latasa M; García BE; Gato JJ; Oehling A
    J Investig Allergol Clin Immunol; 1991 Oct; 1(5):293-301. PubMed ID: 1727011
    [TBL] [Abstract][Full Text] [Related]  

  • 30.
    Kowal K; Bielecki P; DuBuske IV; DuBuske LM
    Allergy Asthma Proc; 2017 May; 38(3):204-215. PubMed ID: 28441991
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recombinant IL-3 induces histamine release from human basophils.
    MacDonald SM; Schleimer RP; Kagey-Sobotka A; Gillis S; Lichtenstein LM
    J Immunol; 1989 May; 142(10):3527-32. PubMed ID: 2469718
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Granulocyte-macrophage colony-stimulating factor and interleukin-3 cause basophil histamine release by a common pathway: downregulation by sodium.
    Tedeschi A; Salmaso C; Di Donato M; Lorini M; Miadonna A
    Immunology; 1999 Feb; 96(2):164-70. PubMed ID: 10233691
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Allergenic epitopes of ovalbumin (OVA) in patients with hen's egg allergy: inhibition of basophil histamine release by haptenic ovalbumin peptide.
    Honma K; Kohno Y; Saito K; Shimojo N; Horiuchi T; Hayashi H; Suzuki N; Hosoya T; Tsunoo H; Niimi H
    Clin Exp Immunol; 1996 Mar; 103(3):446-53. PubMed ID: 8608645
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of terfenadine on the immediate and late-phase reactions mediated by immunoglobulin E.
    de Weck AL; Derer T; Bischoff SC; Takafuji S
    Int Arch Allergy Immunol; 1993; 101(3):326-32. PubMed ID: 7686799
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased release of histamine in patients with respiratory symptoms related to perfume.
    Elberling J; Skov PS; Mosbech H; Holst H; Dirksen A; Johansen JD
    Clin Exp Allergy; 2007 Nov; 37(11):1676-80. PubMed ID: 17877753
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Basophil releasability in the newborn: factors limiting immunoglobulin E-mediated histamine release.
    Mendoza GR; Minagawa K; Orner FB; Stiehm ER
    Pediatrics; 1982 Feb; 69(2):188-92. PubMed ID: 6173838
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Allergy to suxamethonium: persisting abnormalities in skin tests, specific IgE antibodies and leucocyte histamine release.
    Didier A; Benzarti M; Senft M; Charpin D; Lagier F; Charpin J; Vervloet D
    Clin Allergy; 1987 Sep; 17(5):385-92. PubMed ID: 2445504
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The diagnostic value of basophil activation test in patients with an immediate hypersensitivity reaction to radiocontrast media.
    Pinnobphun P; Buranapraditkun S; Kampitak T; Hirankarn N; Klaewsongkram J
    Ann Allergy Asthma Immunol; 2011 May; 106(5):387-93. PubMed ID: 21530870
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human basophil activation measured by CD63 expression and LTC4 release in IgE-mediated food allergy.
    Moneret-Vautrin DA; Sainte-Laudy J; Kanny G; Frémont S
    Ann Allergy Asthma Immunol; 1999 Jan; 82(1):33-40. PubMed ID: 9988204
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of histamine release from basophils in whole blood by benzylpenicilloyl poly-L-lysine in penicillin-sensitized patients.
    Koller DY; Rosenkranz AR; Pirker C; Götz M; Jarisch R
    Allergy; 1992 Oct; 47(5):459-62. PubMed ID: 1283059
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.